TriplePoint Venture Growth BDC

source: coverage-next-full | ticker: TPVG | step: "01" | created: 2026-05-29

Step 01 — Business Overview: TPVG (TriplePoint Venture Growth BDC Corp.)

Executive Summary

TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) is a specialty finance company that has elected to be regulated as a Business Development Company (BDC) under the Investment Company Act of 1940. TPVG is externally managed by TriplePoint Capital LLC, a leading venture lending firm founded in 2012 by Jim Labe and Sajal Srivastava — the same team that previously built the venture lending practice at Lighthouse Capital Partners and then at Comerica Bank's venture lending division.

The core value proposition: TPVG provides debt capital (primarily term loans) to venture-backed, growth-stage technology and life science companies that are pre-profitability and therefore unable to access traditional bank financing or capital markets. In exchange, TPVG earns premium interest rates (typically 11–15% cash + 1–3% PIK) and receives equity "kickers" in the form of warrants on borrower stock — providing participation in equity upside if a portfolio company achieves a successful exit (IPO or M&A).

What Makes TPVG Unique Among BDCs

TPVG is a pure-play venture lending BDC — the only publicly traded BDC almost exclusively focused on VC-backed growth-stage companies. This contrasts with:

• Hercules Capital (HTGC): Similar strategy but broader sector coverage, larger scale (~$4B assets vs. TPVG ~$800M–$1B), and internally managed (cost advantage)
• Traditional BDCs (ARCC, MAIN, GBDC): Middle market lending to profitable companies; lower yield but lower credit risk
• Silicon Valley Bank (SIVB): Was the dominant venture lending bank; its March 2023 collapse removed a major competitor and briefly created significant opportunity for TPVG/HTGC

Business Model

Revenue Generation

1. Interest Income (~85–90% of revenue): Floating rate loans (SOFR/Prime + spread) plus fixed floors, generating 12–16% gross yields on the debt portfolio
2. Fee Income (~5–8%): Origination fees, prepayment fees, end-of-term (EOT) payments
3. Dividend/Equity Income (<5%): From equity co-investments alongside debt
4. Warrant Gains (variable): Fair value adjustments and realized gains on warrants received at origination; highly lumpy and dependent on portfolio company exits

The Venture Lending Thesis

• VC-backed companies have strong institutional sponsors (Sequoia, a16z, Benchmark, etc.) with incentive to support companies through difficulty
• Loan-to-value ratios are implicitly low because enterprise value of growth companies often far exceeds outstanding venture debt
• Warrants provide a "free" equity kicker: TPVG receives warrants for 1–5% of a borrower's fully diluted equity at the time of lending
• Post-money valuations from VC rounds provide reference points for NAV marks

Headquarters & Personnel

• HQ: 2755 Sand Hill Road, Menlo Park, CA 94025 (Silicon Valley heartland; same road as Sequoia, KKR, KPCB, etc.)
• Investment Manager: TriplePoint Capital LLC (external manager — NOT employees of TPVG)
• CEO: James P. Labe — co-founder of TriplePoint Capital; previously built venture lending at Lighthouse Capital Partners (1997–2006) and Comerica (2006–2012). Widely regarded as one of the original architects of institutional venture lending
• President/COO: Sajal Srivastava — co-founder; former president of venture banking at Lighthouse Capital; Stanford MBA

Portfolio Characteristics

Investment Selection Criteria

TPVG/TriplePoint Capital targets companies that:

1. Are backed by top-tier VC firms (Tier 1 sponsors)
2. Have achieved product-market fit and are in growth/scale phase
3. Have 12–18 months of cash runway remaining after the loan
4. Have a clear path to a liquidity event (IPO, strategic M&A, or next VC round)
5. Operate in sectors with strong secular tailwinds

IPO History & Capital Structure

• IPO: March 5, 2014 at $15.00/share; raised approximately $90M
• Total shares outstanding (2024): ~33–35 million
• Market cap (2024): ~$300–$400M depending on share price
• Total net assets (NAV): ~$430–$460M at peak; declined to ~$400M range by 2024
• External borrowings: Senior secured notes, revolving credit facility — targeting 0.8–1.0x debt/equity

Key Differentiators vs. HTGC

source: coverage-next-full | ticker: TPVG | step: "04" | created: 2026-05-29

Step 04 — Financial Snapshot: TPVG (FY2021–FY2024)

Key Financial Summary — Annual

Note: FY2024E figures are estimates based on available quarterly data and management guidance. Exact figures subject to final 10-K filing.

NAV Per Share Trajectory — The Central Concern

NAV/share is the most important metric for BDC investors. TPVG's NAV/share has exhibited a structurally declining trend:

Key observation: TPVG has eroded approximately $3.00/share (~20%) in NAV since peak. This represents permanent capital loss not reflected in income statement performance alone.

Net Investment Income vs. Dividends — Coverage Analysis

Dividend history:

• 2014–2019: $1.44/share annual ($0.36/quarter) — paid quarterly
• 2020 (COVID): Dividend cut from $0.36 → $0.31/quarter
• 2021 recovery: Returned to $0.36/quarter ($1.44/year)
• 2023: Increased to $0.39/quarter (+ special dividends in some quarters)
• 2024: Returned to $0.36/quarter as portfolio income declined with portfolio payoffs

TPVG adopted a monthly dividend structure in later years ($0.12–$0.13/month) to better match BDC cash flow patterns.

Income Statement Detail (FY2023 — Most Recent Full Year)

Balance Sheet Snapshot (FY2023)

Portfolio Quality Metrics

Valuation Context

Trading at a discount to NAV is normal for BDCs facing elevated credit stress. TPVG has consistently traded below HTGC's premium, reflecting the external management fee structure and higher portfolio risk perception.

Key Financial Risks to Track

1. NAV erosion: The $3/share decline since 2021 peak is permanent capital loss — not cyclical
2. Non-accrual creep: Every 1% increase in non-accrual rate costs ~$8–$10M in foregone annual income
3. Leverage headroom: At 0.8–1.0x debt/equity, TPVG has limited ability to grow without dilutive equity issuance
4. Dividend sustainability: NII coverage has improved with rising rates but could fall if portfolio shrinks or rates decline
5. Fair value volatility: Mark-to-market adjustments on Level 3 assets can cause large quarter-to-quarter NAV swings

source: coverage-next-full | ticker: TPVG | step: "12" | created: 2026-05-29

Step 12 — Catalysts: TPVG

Near-Term Catalysts (0–12 Months)

1. Non-Accrual Resolution

The single most impactful near-term catalyst is resolution of the current non-accrual book. Each non-accrual loan that is either restructured back to paying status, paid off through a portfolio company M&A, or written off and removed from the balance sheet:

• If resolved positively (paid off/restructured): Immediate income recovery; potential realized gain; NAV stabilization
• If written off: Clean slate effect — removes overhang; future quarters show higher coverage ratios
• Timeline: Ongoing; typical workout period for stressed VC-backed companies is 6–18 months

2. Portfolio Stabilization and Re-Growth

TPVG's portfolio has declined from ~$970M (Q4 2022) to ~$760M (Q3 2024):

• Catalyst trigger: New commitments persistently exceeding repayments; portfolio begins growing
• Effect: Reverses NII compression; demonstrates manager confidence in deal quality; could trigger P/NAV multiple expansion
• Timeline: Q4 2024–Q2 2025; AI lending boom could accelerate

3. VC Market Strengthening

If the VC funding environment continues to recover in 2025:

• More portfolio companies receive follow-on funding → fewer non-accruals
• Existing warrant/equity investments appreciate as company valuations rise
• New deal flow improves in both quality and quantity
• Catalyst trigger: Top-tier VC fund performance reports; IPO window reopening (Stripe, Databricks, Plaid, etc.)
• Timeline: 2025 VC season; major AI company IPOs

4. Dividend Maintenance / Small Increase

• TPVG returning to $0.13/month (from current $0.12) would signal management confidence in earnings power
• Even maintaining the $0.12/month signals stability to yield-focused investors
• Timeline: Monthly announcements; watch for special dividends if spillover builds

5. Rate Stabilization

• Fed pausing rate cuts would protect NII from further compression
• If market pricing turns rate-stable or slightly higher, floating-rate portfolio benefits accrue
• Timeline: FOMC meetings; Fed communication on terminal rate

Medium-Term Catalysts (1–3 Years)

6. Major Warrant Monetization Event

The AI investment boom of 2023–2025 is creating companies that will ultimately go public or be acquired:

• If one or more TPVG portfolio companies with large warrant positions exit at premium valuations, warrant gains could be $10–$50M+ in a single year
• Historical: In 2021, warrant gains added ~$0.75/share to total return
• Trigger: IPO wave for AI-native companies; strategic acquisitions in tech
• Timeline: 2025–2027 for AI-era IPO cycle

7. SVB Replacement Thesis Plays Out

TPVG is positioned as a primary beneficiary of the SVB void:

• As institutional trust returns to specialty venture lenders (vs. banks), TPVG could grow to $1.2–1.5B in AUM
• Larger portfolio → more NII → higher dividend coverage → potential dividend increase
• Timeline: 2025–2027

8. Internalization Optionality

While speculative, if TriplePoint Capital were to internalize TPVG management (common in maturing BDC stories):

• Fee drag of ~$22M/year disappears
• P/NAV discount vs. HTGC would narrow
• Could be worth $2–3/share in NAV equivalent
• Timeline: Uncertain; requires board and shareholder action; not currently on management's stated agenda

Negative Catalysts (Downside Risks)

9. Dividend Cut

• If NII coverage falls below ~100% and spillover is insufficient, a dividend cut becomes necessary
• Would likely trigger significant selling from income-focused investors
• Could compress P/NAV further from already-discounted levels

10. Prolonged Non-Accrual Escalation

• If non-accruals rise from ~8.5% to 12–15% of portfolio cost, NAV could decline another $2–3/share
• Triggered by: Further VC funding contraction, macro recession, AI bubble burst

11. Refinancing Shock

• 2025 and 2026 note maturities at higher rates could increase interest expense by $6M+/year
• Combined with declining NII, dividend coverage could fall below 100%

Bull Case

• The 2022–2023 VC correction has passed its worst point and non-accruals have peaked; TPVG's $0.86x P/NAV discount resolves as portfolio quality becomes visible, AI investment boom drives record new commitments, and warrant monetization from an AI-era IPO cycle adds $0.50–$1.00/share in gains; 2–3 year total return of 30–45% (dividends + NAV recovery + P/NAV re-rating)
• SVB's permanent exit from venture lending and TPVG's strong VC sponsor relationships position it to grow AUM from ~$760M toward $1.2B; a larger portfolio with improved credit quality restores NII coverage to 130%+ and enables a dividend increase to $1.56/year or higher
• A potential internalization of management (eliminating ~$22M/year in external fees) would immediately add ~$2/share in NAV equivalent and close the P/NAV gap to HTGC's premium valuation (~1.0–1.1x NAV)

Bear Case

• Non-accruals remain elevated at 8–10% of portfolio cost through 2025–2026, as VC-backed companies continue to fail in a higher-for-longer rate environment; realized credit losses erode NAV to $9–$10/share and force a 20–25% dividend cut that re-prices the stock at an even wider discount
• The competitive moat that TPC once held is structurally eroded by bank competition (JP Morgan, HSBC Innovation Banking, Western Alliance) offering lower rates post-SVB, compressing new loan spreads and reducing deal flow; TPVG's premium portfolio yield normalizes toward 12–13% all-in vs. ~17% today
• External management fee structure (1.75% on gross assets) proves terminal: as interest rates decline and portfolio yield compresses, the NII margin is squeezed between falling income and fixed fee extraction, making TPVG uninvestable relative to HTGC at any reasonable P/NAV without a management structure change that management shows no intention of pursuing